121 related articles for article (PubMed ID: 11369137)
1. Sensitivity of cancer cell lines to the novel non-toxic type 2 ribosome-inactivating protein nigrin b.
Muñoz R; Arias Y; Ferreras JM; Jiménez P; Rojo MA; Girbés T
Cancer Lett; 2001 Jun; 167(2):163-9. PubMed ID: 11369137
[TBL] [Abstract][Full Text] [Related]
2. Differential sensitivity of HELA cells to the type 2 ribosome-inactivating proteins ebulin l, nigrin b and nigrin f as compared with ricin.
Citores L; Muñoz R; De Benito FM; Iglesias R; Ferreras JM; Girbes T
Cell Mol Biol (Noisy-le-grand); 1996 Jun; 42(4):473-6. PubMed ID: 8828902
[TBL] [Abstract][Full Text] [Related]
3. Targeting cancer cells with transferrin conjugates containing the non-toxic type 2 ribosome-inactivating proteins nigrin b or ebulin l.
Citores L; Ferreras JM; Muñoz R; Benítez J; Jiménez P; Girbés T
Cancer Lett; 2002 Oct; 184(1):29-35. PubMed ID: 12104045
[TBL] [Abstract][Full Text] [Related]
4. Toxicity and cytotoxicity of nigrin b, a two-chain ribosome-inactivating protein from Sambucus nigra: comparison with ricin.
Battelli MG; Citores L; Buonamici L; Ferreras JM; de Benito FM; Stirpe F; Girbés T
Arch Toxicol; 1997; 71(6):360-4. PubMed ID: 9195017
[TBL] [Abstract][Full Text] [Related]
5. Specific dose-dependent damage of Lieberkühn crypts promoted by large doses of type 2 ribosome-inactivating protein nigrin b intravenous injection to mice.
Gayoso MJ; Muñoz R; Arias Y; Villar R; Rojo MA; Jiménez P; Ferreras JM; Aranguez I; Girbés T
Toxicol Appl Pharmacol; 2005 Sep; 207(2):138-46. PubMed ID: 16102565
[TBL] [Abstract][Full Text] [Related]
6. Interaction of volkensin with HeLa cells: binding, uptake, intracellular localization, degradation and exocytosis.
Battelli MG; Musiani S; Buonamici L; Santi S; Riccio M; Maraldi NM; Girbés T; Stirpe F
Cell Mol Life Sci; 2004 Aug; 61(15):1975-84. PubMed ID: 15289938
[TBL] [Abstract][Full Text] [Related]
7. Non-toxic type 2 ribosome-inactivating proteins (RIPs) from Sambucus: occurrence, cellular and molecular activities and potential uses.
Girbes T; Ferreras JM; Arias FJ; Muñoz R; Iglesias R; Jimenez P; Rojo MA; Arias Y; Perez Y; Benitez J; Sanchez D; Gayoso MJ
Cell Mol Biol (Noisy-le-grand); 2003 Jun; 49(4):537-45. PubMed ID: 12899446
[TBL] [Abstract][Full Text] [Related]
8. Targeting a marker of the tumour neovasculature using a novel anti-human CD105-immunotoxin containing the non-toxic type 2 ribosome-inactivating protein nigrin b.
Muñoz R; Arias Y; Ferreras JM; Rojo MA; Gayoso MJ; Nocito M; Benitez J; Jiménez P; Bernabéu C; Girbés T
Cancer Lett; 2007 Oct; 256(1):73-80. PubMed ID: 17637501
[TBL] [Abstract][Full Text] [Related]
9. Evidence for distinct cellular internalization pathways of ricin and nigrin b.
Citores L; Muñoz R; Rojo MA; Jiménez P; Ferreras JM; Girbés T
Cell Mol Biol (Noisy-le-grand); 2003; 49 Online Pub():OL461-5. PubMed ID: 14995076
[TBL] [Abstract][Full Text] [Related]
10. Isolation and partial characterization of nigrin b, a non-toxic novel type 2 ribosome-inactivating protein from the bark of Sambucus nigra L.
Girbés T; Citores L; Ferreras JM; Rojo MA; Iglesias R; Muñoz R; Arias FJ; Calonge M; García JR; Méndez E
Plant Mol Biol; 1993 Sep; 22(6):1181-6. PubMed ID: 8400135
[TBL] [Abstract][Full Text] [Related]
11. The lower cytotoxicity of cinnamomin (a type II RIP) is due to its B-chain.
Wang BZ; Zou WG; Liu WY; Liu XY
Arch Biochem Biophys; 2006 Jul; 451(1):91-6. PubMed ID: 16762311
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics in the rat of a panel of immunotoxins made with abrin A chain, ricin A chain, gelonin, and momordin.
Wawrzynczak EJ; Cumber AJ; Henry RV; May J; Newell DR; Parnell GD; Worrell NR; Forrester JA
Cancer Res; 1990 Dec; 50(23):7519-26. PubMed ID: 2253201
[TBL] [Abstract][Full Text] [Related]
13. Characterization and molecular cloning of Sambucus nigra agglutinin V (nigrin b), a GalNAc-specific type-2 ribosome-inactivating protein from the bark of elderberry (Sambucus nigra).
Van Damme EJ; Barre A; Rougé P; Van Leuven F; Peumans WJ
Eur J Biochem; 1996 Apr; 237(2):505-13. PubMed ID: 8647092
[TBL] [Abstract][Full Text] [Related]
14. Comparative studies on kinetics of inhibition of protein synthesis in intact cells by ricin and a conjugate of ricin B-chain with momordin.
Sharma S; Podder SK; Karande AA
Mol Cell Biochem; 1999 Oct; 200(1-2):133-41. PubMed ID: 10569193
[TBL] [Abstract][Full Text] [Related]
15. Detection of ricin and other ribosome-inactivating proteins by an immuno-polymerase chain reaction assay.
Lubelli C; Chatgilialoglu A; Bolognesi A; Strocchi P; Colombatti M; Stirpe F
Anal Biochem; 2006 Aug; 355(1):102-9. PubMed ID: 16762307
[TBL] [Abstract][Full Text] [Related]
16. Toxicity of ricin and volkensin, two ribosome-inactivating proteins, to microglia, astrocyte, and neuron cultures.
Sparapani M; Buonamici L; Ciani E; Battelli MG; Ceccarelli G; Stirpe F; Contestabile A
Glia; 1997 Jul; 20(3):203-9. PubMed ID: 9215729
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the embryotoxic effects of saporin, agrostin (type 1 ribosome-inactivating proteins) and ricin (a type 2 ribosome-inactivating protein).
Chan WY; Ng TB
Pharmacol Toxicol; 2001 Jun; 88(6):300-3. PubMed ID: 11453369
[TBL] [Abstract][Full Text] [Related]
18. Constitutive and inducible type 1 ribosome-inactivating proteins (RIPs) in elderberry (Sambucus nigra L.).
de Benito FM; Iglesias R; Ferreras JM; Citores L; Camafeita E; Méndez E; Girbés T
FEBS Lett; 1998 May; 428(1-2):75-9. PubMed ID: 9645479
[TBL] [Abstract][Full Text] [Related]
19. Evidence for the importance of electrostatics in the function of two distinct families of ribosome inactivating toxins.
Korennykh AV; Correll CC; Piccirilli JA
RNA; 2007 Sep; 13(9):1391-6. PubMed ID: 17626843
[TBL] [Abstract][Full Text] [Related]
20. Isolation and partial characterization of a novel and uncommon two-chain 64-kDa ribosome-inactivating protein from the bark of elder (Sambucus nigra L.).
de Benito FM; Citores L; Iglesias R; Ferreras JM; Camafeita E; Méndez E; Girbés T
FEBS Lett; 1997 Aug; 413(1):85-91. PubMed ID: 9287122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
